Follow the Kilitch Drugs (India) Limited share price and the full management transaction log of the company, a listed issuer based in India. Shares are quoted on the IN market, under the oversight of SEBI (PIT + SAST). Operating in the Health Care sector, Kilitch Drugs (India) Limited has logged 5 insider filings. Market capitalisation: €6.5bn. The latest transaction was reported on 27 August 2024 (Sale). Among the most active insiders: Bhavin Mehta. All data is openly available.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
5 of 5 declarations
Kilitch Drugs (India) Limited is a company engaged in the manufacturing of pharmaceutical products. It operates on the Bombay Stock Exchange.